These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 822325

  • 1. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
    Mohn GR, Ellenberger J.
    Mutat Res; 1976; 32(3-4):331-60. PubMed ID: 822325
    [No Abstract] [Full Text] [Related]

  • 2. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
    Ellenberger J, Mohn G.
    Arch Toxicol; 1975; 33(3):225-40. PubMed ID: 1096853
    [Abstract] [Full Text] [Related]

  • 3. Mutagenic activity of cyclophosphamide, trofosfamide, and ifosfamide in drosophila melanogaster. specific induction of recessive lethals in the absence of detectable chromosome breakage.
    Vogel E.
    Mutat Res; 1975 Dec; 33(2-3):221-8. PubMed ID: 814451
    [Abstract] [Full Text] [Related]

  • 4. The oxazaphosphorines.
    Brock N.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():3-15. PubMed ID: 6627244
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of cellular immune reactions by cyclophosphamide analogues ifosfamide and trofosfamide. I. Mixed lymphocyte reaction.
    Devlin RG, Schwartz NL, Baronowsky PE, Zygmunt WA.
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):389-91. PubMed ID: 4273394
    [No Abstract] [Full Text] [Related]

  • 6. Inactivation and mutation induction in bacteria by microsomal metabolites.
    Garner RC.
    Biochem Soc Trans; 1975 Feb; 3(1):65-9. PubMed ID: 1092573
    [No Abstract] [Full Text] [Related]

  • 7. Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).
    Ehling UH, Favor J, Neuhäuser-Klaus A, Adler ID.
    Genet Res; 1998 Dec; 72(3):177-83. PubMed ID: 10036972
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of the antimitotic effects of cyclophosphamide, trofosfamide and ifosfamide on meristema plant cells and animal cells in in vitro culture].
    Deysson G, Adolphe M, Semont H.
    C R Seances Soc Biol Fil; 1981 Dec; 175(2):177-81. PubMed ID: 6454463
    [No Abstract] [Full Text] [Related]

  • 9. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
    Benedict WF, Baker MS, Haroun L, Choi E, Ames BN.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
    [Abstract] [Full Text] [Related]

  • 10. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
    Norpoth K, Addicks HW, Witting U, Mŭller G, Raidt H.
    Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A.
    Oesch-Bartlomowicz B, Vogel S, Arens HJ, Oesch F.
    Mutat Res; 1990 Oct; 232(2):305-12. PubMed ID: 2170835
    [Abstract] [Full Text] [Related]

  • 12. The induction of temperature-sensitive mutations in Drosophila melanogaster by the acridine mustard ICR-170.
    Woodruff RC, Gander RM.
    Mutat Res; 1974 Dec; 25(3):337-45. PubMed ID: 4215971
    [No Abstract] [Full Text] [Related]

  • 13. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI, Khromov-Borisov NN.
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H, Radzikowski C, Paprocka M, Budzyński W, Rak J, Kinas R, Misiura K, Stec W.
    J Immunopharmacol; 1986 Mar; 8(4):455-80. PubMed ID: 3805744
    [Abstract] [Full Text] [Related]

  • 15. Some properties of AENY inhibiting factor produced by male strains of Escherichia coli K-12.
    Gol'dfarb DM, Chernin LS, Gol'dberg GI, Akatova NS, Gukova LA.
    Sov Genet; 1970 Oct; 6(10):1360-6. PubMed ID: 4950368
    [No Abstract] [Full Text] [Related]

  • 16. Vinyl chloride--Part 2: Mutagenicity.
    Hopkins J.
    Food Cosmet Toxicol; 1979 Oct; 17(5):542-4. PubMed ID: 118101
    [No Abstract] [Full Text] [Related]

  • 17. The mutagenicity of captan and related fungicides.
    Bridges BA.
    Mutat Res; 1975 Oct; 32(1):3-34. PubMed ID: 124818
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of sperm abnormalities in mice by ifosfamide and trofosfamide.
    Quinto I, De Marinis E, De Dominicis G, Della Morte R, Staiano N.
    Mutat Res; 1988 Sep; 201(1):113-6. PubMed ID: 3419442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.